A randomized controlled trial of adjunctive Bunchang Naoxintong Capsule (步长脑心通胶囊) versus maintenance dose clopidogrel in patients with CYP2C19*2 polymorphism.

MLA

Chen, Hui, et al. “A Randomized Controlled Trial of Adjunctive Bunchang Naoxintong Capsule (步长脑心通胶囊) versus Maintenance Dose Clopidogrel in Patients with CYP2C19*2 Polymorphism.” Chinese Journal of Integrative Medicine, vol. 20, no. 12, Dec. 2014, pp. 894–902. EBSCOhost, https://doi.org/10.1007/s11655-014-2023-z.

APA

Chen, H., Wu, X., Wu, H., & Wang, H. (2014). A randomized controlled trial of adjunctive Bunchang Naoxintong Capsule (步长脑心通胶囊) versus maintenance dose clopidogrel in patients with CYP2C19*2 polymorphism. Chinese Journal of Integrative Medicine, 20(12), 894–902. https://doi.org/10.1007/s11655-014-2023-z

Chicago

Chen, Hui, Xiao-ying Wu, Hong-xia Wu, and Huan Wang. 2014. “A Randomized Controlled Trial of Adjunctive Bunchang Naoxintong Capsule (步长脑心通胶囊) versus Maintenance Dose Clopidogrel in Patients with CYP2C19*2 Polymorphism.” Chinese Journal of Integrative Medicine 20 (12): 894–902. doi:10.1007/s11655-014-2023-z.